23.01.2014 • News

Bayer €2 billion Bond Issue Will Fund Debt Capital

Bayer has launched a bond issue worth €2 billion, taking advantage of low interest rates to raise debt capital. The German group said proceeds from the issue of three Eurobonds through a consortium involving seven banks will be used for general corporate purposes and possible acquisitions.

The €500 million two-year floating-rate Eurobond was issued at an interest rate of 22 basis points over three-month Euribor, Bayer said. The €750 million four-year fixed-rate Eurobond carries a coupon of 1.125%, and the €750 million seven-year fixed-rate Eurobond carries a coupon of 1.875%.

The bonds are said to have met with "exceptionally high demand" from capital markets. The order book was over four times oversubscribed.

Bayer's "successful placement of these benchmark bonds" confirms its high standing on the capital market, said chief financial officer Werner Baumann, adding that the group has leveraged its strong position as an issuer.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.